Open AccessEffects of solid‐phase extraction of plasma in measuring gut metabolic hormones in fasted and fed blood of lean and diet‐induced obese rats
Author(s) -
Reidelberger Roger,
Haver Alvin,
Anders Krista,
Apenteng Bettye,
Lanio Craig
Publication year - 2016
Publication title -
physiological reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 39
ISSN - 2051-817X
DOI - 10.14814/phy2.12800
Subject(s) - amylin , medicine , endocrinology , leptin , peptide yy , ghrelin , postprandial , insulin , hormone , chemistry , incretin , obesity , diabetes mellitus , neuropeptide y receptor , neuropeptide , type 2 diabetes , islet , receptor
Abstract Glucagon‐like peptide‐1 ( GLP ‐1), peptide YY (3‐36) [ PYY (3‐36)], amylin, ghrelin, insulin, and leptin are thought to act as hormonal signals from periphery to brain to control food intake. Here, we determined the effects of solid‐phase extraction of plasma in measuring these hormones in blood of lean and diet‐induced obese rats. Individual enzyme‐linked immunoassays and a multiplex assay were used to measure active GLP ‐1, total PYY , active amylin, active ghrelin, insulin, leptin, and total GIP in response to (1) addition of known amounts of the peptides to lean and obese plasma, (2) a large meal in lean and obese rats, and (3) intravenous infusions of anorexigenic doses of GLP ‐1, PYY (3‐36), amylin, and leptin in lean rats. Extraction of lean and obese plasma prior to assays produced consistent recoveries across assays for GLP ‐1, PYY , amylin, ghrelin, and insulin, reflecting losses inherent to the extraction procedure. Plasma extraction prior to assays generally revealed larger meal‐induced changes in plasma GLP ‐1, PYY , amylin, ghrelin, and insulin in lean and obese rats. Plasma extraction and the multiplex assay were used to compare plasma levels of GLP ‐1, PYY , and amylin after a large meal with plasma levels produced by IV infusions of anorexigenic doses of GLP ‐1, PYY (3‐36), and amylin. Infusions produced dose‐dependent increases in plasma peptide levels, which were well above their postprandial levels. These results do not support the hypothesis that postprandial plasma levels of GLP ‐1, PYY (3‐36), and amylin are sufficient to decrease food intake by an endocrine mechanism.